President Trump ’s vow to overhaul the Food and Drug Administration could bring major changes in policy , including steps to accelerate the process of approving new prescription drugs , setting up a clash with critics who say President Trump push for deregulation might put consumers at risk .President Trump has been vetting candidates to run the agency , which regulates the safety of everything from drugs and medical devices to food and cosmetics .Among them isJim Mr. O’Neill Mr. O’Neill has argued that companies should not have to prove that their drugs work in clinical trials before selling them to consumers .